[1] Chaudhari VA, Khobragade K, Bhandare M, et al. Management of fibrolamellar hepatocellular carcinoma[J]. Chin Clin Oncol, 2018,7(5):51.
[2] 耿利, 许维智, 林川, 等. 纤维板层型肝癌一例[J]. 中华肝胆外科杂志, 2006,12(10):698.
[3] Edmondson HA. Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood[J]. AMA J Dis Child, 1956,91(2):168-186.
[4] Lemekhova A, Hornuss D, Polychronidis G, et al. Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience[J]. World J Surg Oncol, 2020,18(1):93.
[5] 龙卫国, 吴建农. 纤维板层型肝细胞癌的临床及病理研究进展[J]. 临床与实验病理学杂志, 2011,27(7):751-754.
[6] 罗彦英, 高玉彤, 潘彦珞, 等. 纤维板层型肝细胞癌1例报道及文献复习[J]. 中国肿瘤临床, 2005,32(4):209-211.
[7] Dong Y, Wang WP, Mao F, et al. Imaging features of fibrolamellar hepatocellular carcinoma with contrast-enhanced ultrasound[J]. Ultraschall Med, 2020,DOI: 10.1055/a-1110-7124.
[8] 王少春, 张晓红, 陈东风. 纤维板层型肝细胞癌临床诊断学特征分析并文献复习[J]. 中华诊断学电子杂志, 2013,1(1):51-56.
[9] 龙卫国, 吴建农. 纤维板层型肝细胞癌的临床及病理研究进展[J]. 临床与实验病理学杂志, 2011,27(7):751-754.
[10] 王成林. 肝脏少见类型癌病理、CT和MRI诊断(一)[J]. 中国CT和MRI杂志, 2006,4(1):48-51.
[11] Torbenson M. Review of the clinicopathologic features of fibrolamellar carcinoma[J]. Adv Anat Pathol, 2007,14(3):217-223.
[12] Stevens WR, Johnson CD, Stephens DH, et al. Fibrolamellar hepatocellular carcinoma: stage at presentation and results of aggressive surgical management[J]. AJR Am J Roentgenol, 1995,164(5):1153-1158.
[13] Stipa F, Yoon SS, Liau KH, et al. Outcome of patients with fibrolamellar hepatocellular carcinoma[J]. Cancer, 2006,106(6):1331-1338.
[14] 董辉, 李强. 纤维板层型肝癌的治疗及预后分析[J]. 中华普通外科杂志, 2008,23(2):88-90.
[15] El-Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study[J]. Hepatology, 2004,39(3):798-803. |
